Timmers Marijke, Claeys Marc J, Vanhauwaert Bert, Rivero-Ayerza Maximo, De Hondt Geert
a Department of Cardiology , University Hospital Antwerp , Antwerp , Belgium.
b Department of Cardiology , Mariaziekenhuis Noord-Limburg , Overpelt , Belgium.
Acta Cardiol. 2018 Feb;73(1):1-6. doi: 10.1080/00015385.2017.1325633. Epub 2017 Jul 4.
Cardiac involvement in sarcoidosis can present in various ways, with atrioventricular (AV) block and ventricular arrhythmias being the most common signs. Because of initial non-specific findings, diagnosis can be a challenge. Very few data can support treatment decisions as cardiac manifestations of this systemic disorder are rare.
We reviewed current guidelines, cohort studies, and expert opinions concerning diagnosis and treatment of cardiac sarcoidosis.
Longitudinal follow-up studies are necessary to improve the diagnostic process and risk stratification of cardiac sarcoidosis. The optimal dose of steroids, indications for internal cardioverter-defibrillator (ICD), and technique and optimal timing of ablation are still under debate.
结节病累及心脏可表现为多种形式，其中房室传导阻滞和室性心律失常最为常见。由于最初表现不具特异性，诊断可能具有挑战性。由于这种全身性疾病的心脏表现罕见，几乎没有数据能够支持治疗决策。
我们回顾了有关心脏结节病诊断和治疗的现行指南、队列研究及专家意见。
有必要进行纵向随访研究以改善心脏结节病的诊断流程和风险分层。类固醇的最佳剂量、植入式心脏复律除颤器（ICD）的适应证以及消融技术和最佳时机仍存在争议。
